Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice

The development of a successful vaccine against HIV is likely to require the induction of strong and long-lasting humoral immune responses at the mucosal portal of virus entry. Hence, the design of a vaccine strategy able to induce mucosal antibodies and in particular specific IgA, may be crucial to...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Roey, Griet A, Arias, Mauricio A, Tregoning, John S, Rowe, George, Shattock, Robin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2012
Materias:
Immunity to Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378695/
https://www.ncbi.nlm.nih.gov/pubmed/22057556
http://dx.doi.org/10.1002/eji.201141787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378695/
https://www.ncbi.nlm.nih.gov/pubmed/22057556
http://dx.doi.org/10.1002/eji.201141787

Ejemplares similares